- TheStreet.com•18 days ago
Ionis Pharmaceuticals (IONS) reported 2016 second quarter revenue that beat analysts expectations before today's market open.
- Zacks•18 days ago
Ionis Pharmaceuticals (IONS) reported a loss of 47 cents in second-quarter of 2016, missing the Zacks Consensus Estimate of 48 cents.
Isis Pharmaceuticals, Inc. (ISIS)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|